Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126970441 | 12697044 | 1 | I | 20160829 | 20160830 | 20160830 | EXP | CA-ROCHE-1822199 | ROCHE | 38.00 | YR | F | Y | 0.00000 | 20160830 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126970441 | 12697044 | 1 | PS | TAMIFLU | OSELTAMIVIR PHOSPHATE | 1 | Oral | THERAPY DURATION: 1.0 DAY(S) NOT SPECIFIED | U | 21087 | |||||||||
| 126970441 | 12697044 | 2 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | SOLUTION INTRAVENOUS | U | 0 | 1200 | MG | QOW | ||||||
| 126970441 | 12697044 | 3 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | THERAPY DURATION: 22.0 DAY(S) SOLUTION INTRAVENOUS | U | 0 | 900 | MG | /wk | ||||||
| 126970441 | 12697044 | 4 | C | BETAMETHASONE. | BETAMETHASONE | 1 | Unknown | 0 | |||||||||||
| 126970441 | 12697044 | 5 | C | DOXEPIN | DOXEPIN | 1 | 0 | ||||||||||||
| 126970441 | 12697044 | 6 | C | ERGOCALCIFEROL. | ERGOCALCIFEROL | 1 | Unknown | NOT SPECIFIED | 0 | ||||||||||
| 126970441 | 12697044 | 7 | C | HYDROMORPHONE | HYDROMORPHONE | 1 | Unknown | NOT SPECIFIED | 0 | ||||||||||
| 126970441 | 12697044 | 8 | C | HYDROXYZINE | HYDROXYZINEHYDROXYZINE HYDROCHLORIDE | 1 | Unknown | NOT SPECIFIED | 0 | ||||||||||
| 126970441 | 12697044 | 9 | C | NEVANAC | NEPAFENAC | 1 | Unknown | SUSPENSION OPHTHALMIC | 0 | ||||||||||
| 126970441 | 12697044 | 10 | C | PANTOLOC | PANTOPRAZOLE SODIUM | 1 | Unknown | 0 | GASTRO-RESISTANT COATED TABLET | ||||||||||
| 126970441 | 12697044 | 11 | C | RAMIPRIL. | RAMIPRIL | 1 | Unknown | NOT SPECIFIED | 0 | ||||||||||
| 126970441 | 12697044 | 12 | C | VANCOMYCIN | VANCOMYCIN | 1 | Unknown | NOT SPECIFIED | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126970441 | 12697044 | 1 | Viral infection |
| 126970441 | 12697044 | 2 | Haemolytic uraemic syndrome |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126970441 | 12697044 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126970441 | 12697044 | Blood potassium increased | |
| 126970441 | 12697044 | Viral infection | |
| 126970441 | 12697044 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |